Skip to content

Author

E. Postovalova

We have 2 of 58 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

Clinical utility of real-time comprehensive molecular testing in large B-cell lymphoma.

The clinical utility and acceptable TAT of a comprehensive WES and RNA-seq assay for LBCL managed in routine clinical practice are demonstrated and support the real-world feasibility of using integrated WES and RNA-seq to define molecular subgroups, guide clinical decision-making at the time of a new line of therapy, a...

Dai Chihara, Kumudha Balakrishnan, G. Masand et al. · 0 citations
Open access Aug 2026

Malignant B-cell States Orchestrate Spatially Organized Immune Ecosystems in B-cell Lymphomas

Findings establish malignant differentiation state as a causal determinant of immune architecture across GC-derived lymphomas and identify lineage-directed immune reprogramming as a potential therapeutic strategy.

P. Mondello, A. Sadekova, ksenia fede et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.